Cubebio Co., Ltd
CUBEBIO is a biomedical company, headquartered in Seoul, South Korea, dedicated to research and development of cancer diagnostic biomarkers and in vitro diagnostics. The company possesses more than 30 patents in relation to cancer diagnosis. Since its establishment, CUBEBIO has committed itself to continuous research and development for global health improvements by focusing on early cancer detection through self-diagnosis by means of urine as a specimen.
CUBEBIO’s self-diagnostic device, which is able to detect 8 most common cancer types, enables anyone to check their cancer status frequently, thereby making early screening possible and, in the case of cancer patients, allowing them to monitor their cancer for progression or recurrence.
CUBEBIO works toward creating a new global culture where people are empowered to take responsibility for their own health and the health of their families by self-diagnosing cancers at an early stage easily, accurately, and inexpensively in a variety of settings, including home, hospital, pharmacy, coffee shop, bank, convenience store, and school, regardless of time. Thus, CUBEBIO aims to emerge as a new global leader in the healthcare industry.